(HealthDay News) — For patients newly diagnosed with atrial fibrillation (AF) during hospitalization for other causes, most are not dispensed anticoagulants in the year after discharge, although some ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Endo, Inc. (OTCQX: NDOI) announced today the launch of a Spatial Computing Injection Simulator for Peyronie's disease. The ...

For patients newly diagnosed with atrial fibrillation (AF) during hospitalization for other causes, most are not dispensed ...

UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

Combining oral anticoagulation and antiplatelet therapy post-stroke offers no added protection against recurrence but raises ...

You might have a preferred over-the-counter medication that just seems to metabolize effectively in your body to bring down ...

Most of us know someone who’s taking medicine to manage cholesterol levels, if we’re not the ones taking it ourselves. In ...

A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity-two issues ...